Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Sonoma Pharmaceuticals stock

Learn how to easily invest in Sonoma Pharmaceuticals stock.

Sonoma Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Sonoma Pharmaceuticals shares (SNOA) are listed on the NASDAQ and all prices are listed in US Dollars. Sonoma Pharmaceuticals employs 12 staff and has a trailing 12-month revenue of around $12.9 million.

How to buy shares in Sonoma Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SNOA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Sonoma Pharmaceuticals stock price (NASDAQ: SNOA)

Use our graph to track the performance of SNOA stocks over time.

Sonoma Pharmaceuticals shares at a glance

Information last updated 2022-09-24.
Latest market close$2.13
52-week range$2.17 - $8.76
50-day moving average $3.01
200-day moving average $3.40
Wall St. target price$9.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.42

Buy Sonoma Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Sonoma Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sonoma Pharmaceuticals price performance over time

Historical closes compared with the close of $2.13 from 2022-09-30

1 week (2022-09-23) -2.29%
1 month (2022-09-01) -22.22%
3 months (2022-07-01) -27.30%
6 months (2022-04-01) -41.96%
1 year (2021-09-27) N/A
2 years (2020-10-01) -74.82%
3 years (2019-10-01) 5.76
5 years (2017-09-29) 5.22

Sonoma Pharmaceuticals financials

Revenue TTM $12.9 million
Gross profit TTM $4 million
Return on assets TTM -23.33%
Return on equity TTM -77.5%
Profit margin -37.71%
Book value $2.57
Market capitalisation $6.8 million

TTM: trailing 12 months

Sonoma Pharmaceuticals share dividends

We're not expecting Sonoma Pharmaceuticals to pay a dividend over the next 12 months.

Have Sonoma Pharmaceuticals's shares ever split?

Sonoma Pharmaceuticals's shares were split on a 1:9 basis on 20 June 2019. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sonoma Pharmaceuticals shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Sonoma Pharmaceuticals shares which in turn could have impacted Sonoma Pharmaceuticals's share price.

Sonoma Pharmaceuticals share price volatility

Over the last 12 months, Sonoma Pharmaceuticals's shares have ranged in value from as little as $2.17 up to $8.76. A popular way to gauge a stock's volatility is its "beta".

SNOA.US volatility(beta: 0.95)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sonoma Pharmaceuticals's is 0.9505. This would suggest that Sonoma Pharmaceuticals's shares are less volatile than average (for this exchange).

Sonoma Pharmaceuticals overview

Sonoma Pharmaceuticals, Inc. , develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc.

Frequently asked questions

What percentage of Sonoma Pharmaceuticals is owned by insiders or institutions?
Currently 0.386% of Sonoma Pharmaceuticals shares are held by insiders and 5.962% by institutions.
How many people work for Sonoma Pharmaceuticals?
Latest data suggests 12 work at Sonoma Pharmaceuticals.
When does the fiscal year end for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals's fiscal year ends in March.
Where is Sonoma Pharmaceuticals based?
Sonoma Pharmaceuticals's address is: 645 Molly Lane, Woodstock, GA, United States, 30189
What is Sonoma Pharmaceuticals's ISIN number?
Sonoma Pharmaceuticals's international securities identification number is: US83558L2043
What is Sonoma Pharmaceuticals's CUSIP number?
Sonoma Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 67575P108

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site